Artboard 1Icon/UI/CalendarIcons/Ionic/Social/social-pinterest

Inside track: Healthcare

24 November 2020

#Construction & Infrastructure

Inside track: Healthcare

In the media

Seqirus to build $800m flu vaccine facility in Melbourne
Influenza vaccine provider Seqirus has announced plans to construct a world-class biotech manufacturing facility in Australia to supply influenza vaccines to Australia and the rest of the world (18 November 2020).  More...

Wollongong Hospital finds solution to connect ICU patients with their families
The hospital is mitigating the impact of ICU visitor restrictions with HowRU – a bespoke solution that uses video and collaboration technology to help families (17 November 2020).  More...

Lifeblood Milk and SAHMRI partner to deliver Australia’s first breast milk fortifier for premature babies
Breast milk donated by Australian mothers will for the first time be used to create a “milk fortifier” prototype – a nutrient dense supplement that can help premature and low-weight babies grow (17 November 2020).  More...

CSIRO solution creates smarter, safer homes for independent seniors
Australia’s national science agency, CSIRO, has developed a new health monitoring solution that will enable older Australians living independently at home to send real-time data to their healthcare providers (16 November 2020).  More...

World-first skin cancer treatment aims to help transplant patients
A new medication which can be applied to the skin could help prevent organ transplant recipients from developing harmful skin cancers. The world-first treatment being developed at The University of Queensland is the only drug of its type that could prevent the incidence of skin cancers for transplant patients (19 November 2020).  More...

New drug research for prostate cancer could also fight COVID-19
Two drugs under development to treat aggressive prostate cancer will now be tested to combat the deadliest response to COVID-19 infection – acute respiratory distress syndrome (16 November 2020).  More...

Disclaimer
The information in this publication is of a general nature and is not intended to address the circumstances of any particular individual or entity. Although we endeavour to provide accurate and timely information, we do not guarantee that the information in this newsletter is accurate at the date it is received or that it will continue to be accurate in the future.

Share this